Coronavirus (COVID-19): What the HHS and CDC Are Recommending to HIV/AIDS Clinicians
Multiple U.S. health agencies have released HIV-specific information, and research on HIV and the novel coronavirus is trickling in. Here's what health care providers need to know.
My Former Patient was Denied PEP at a Big Atlanta HIV Organization. Here's What I Did.
David Malebranche's former patient tried to get PEP at a major Atlanta HIV clinic and was initally denied. Though the situation has been made right, it's important to make sure this doesn't happen again.
This Week in HIV Research: The Frustrating Relativity of Efficacy
March 26, 2020: Lopinavir/ritonavir falls short against COVID-19; impact of PrEP scale-up on HIV diagnoses; long-term cost-effectiveness of various HIV interventions; disparities in virologic suppression among young people.
Some Research on Pregnant and Postpartum Women with HIV Is Presented at CROI, But More Trials Are Needed
Pregnant people who are living with or vulnerable to HIV need to be included in clinical trials in order to close our knowledge gaps.
Our Newest Posts
This Week in HIV Research: In Every Cloud, a Silver Lining
April 2, 2020: Physical activity vs. heart med adherence; reducing the burden of HIV emergency care; increasing smoking cessation intervention success; virologic failure following asymptomatic HIV treatment initiation.
Why Do Researchers Think HIV Meds Might Work Against COVID-19?
At least one such drug still holds that promise against coronavirus, but in general there’s little precedent for the same drug blocking different viruses.
U.S. Lawmakers, Advocates Say Coronavirus Pandemic Requires Revision in Gay Blood Donor Ban
Advocates and public health organizations say the 2015 policy revision still stigmatizes gay men and isn’t based on science.
Has Deborah Birx Crossed the Line?
Widely respected by U.S. and African activists for her work on global AIDS, she’s also increasingly seen as playing fast and loose with COVID facts to appease President Trump.
Addressing Coronavirus in African Countries With High HIV Rates: An Interview With UNAIDS Head Winnie Byanyima
Byanyima discusses COVID-19, HIV, and the power of the community response.
America, Meet Tony Fauci. AIDS Activists Have Known Him a Long Time
Thirty years ago, the NIH legend deftly negotiated between bureaucrats and activists. As part of Trump’s COVID-19 team, can he negotiate between loyalty and truth?
Refer your clients and patients to TheBody, TheBodyPro's sibling site for people living with or affected by HIV. TheBody delivers vital information, news, support, and personal perspectives on HIV and related issues.
